XML 104 R60.htm IDEA: XBRL DOCUMENT v3.19.3.a.u2
Financing Arrangements - Narrative (Details)
1 Months Ended 3 Months Ended 9 Months Ended
Aug. 30, 2019
USD ($)
Jul. 31, 2019
USD ($)
Jun. 30, 2019
USD ($)
Jul. 26, 2019
USD ($)
Jan. 24, 2020
USD ($)
Jan. 25, 2019
USD ($)
Jun. 30, 2019
EUR (€)
tranche
Apr. 26, 2019
USD ($)
Senior Notes                
Principal value         $ 25,200,000,000     $ 25,000,000,000.0
Cash proceeds, net of discounts and issuance costs         5,568,000,000 $ 3,000,000    
Loss on extinguishment of debt         406,000,000 $ 0    
Financial Instruments Not Measured at Fair Value                
Long-term debt, including the current portion, fair value         27,500,000,000     26,200,000,000
Commercial Paper Program | Commercial Paper                
Commercial Paper [Abstract]                
Commercial paper, maximum borrowing amount         3,500,000,000      
Commercial paper, amount outstanding         0     0
Credit Facility | Line of Credit                
Line of Credit Facility                
Line of credit, maximum capacity         $ 3,500,000,000      
Term of debt instrument         5 years      
Line of credit, amount outstanding         $ 0     $ 0
Senior Notes 2019 | Senior notes | Medtronic Luxco                
Senior Notes                
Number of tranches | tranche             6  
Principal value | €             € 5,000,000,000.0  
Cash proceeds, net of discounts and issuance costs     $ 5,600,000,000          
Floating Rate Notes due 2021 | Senior notes                
Line of Credit Facility                
Term of debt instrument         2 years      
Floating Rate Notes due 2021 | Senior notes | Medtronic Luxco                
Senior Notes                
Principal value | €             250,000,000  
0.000 percent four-year 2019 senior notes | Senior notes                
Line of Credit Facility                
Term of debt instrument         4 years      
Senior Notes                
Stated interest rate         0.00%      
0.000 percent four-year 2019 senior notes | Senior notes | Medtronic Luxco                
Senior Notes                
Principal value | €             € 750,000,000  
Stated interest rate             0.00%  
0.250 percent seven-year 2019 senior notes | Senior notes                
Line of Credit Facility                
Term of debt instrument         7 years      
Senior Notes                
Stated interest rate         0.25%      
0.250 percent seven-year 2019 senior notes | Senior notes | Medtronic Luxco                
Senior Notes                
Principal value | €             € 1,000,000,000.0  
Stated interest rate             0.25%  
1.000 percent thirteen-year 2019 senior notes | Senior notes                
Line of Credit Facility                
Term of debt instrument         13 years      
Senior Notes                
Stated interest rate         1.00%      
1.000 percent thirteen-year 2019 senior notes | Senior notes | Medtronic Luxco                
Senior Notes                
Principal value | €             € 1,000,000,000.0  
Stated interest rate             1.00%  
1.500 percent twenty-year 2019 senior notes | Senior notes                
Line of Credit Facility                
Term of debt instrument         20 years      
Senior Notes                
Stated interest rate         1.50%      
1.500 percent twenty-year 2019 senior notes | Senior notes | Medtronic Luxco                
Senior Notes                
Principal value | €             € 1,000,000,000.0  
Stated interest rate             1.50%  
1.750 percent thirty-year 2019 senior notes | Senior notes                
Line of Credit Facility                
Term of debt instrument         30 years      
Senior Notes                
Stated interest rate         1.75%      
1.750 percent thirty-year 2019 senior notes | Senior notes | Medtronic Luxco                
Senior Notes                
Principal value | €             € 1,000,000,000.0  
Stated interest rate             1.75%  
Medtronic Inc, CIFSA, and Medtronic Luxco Senior Notes | Senior notes                
Senior Notes                
Extinguishment of debt $ 533,000,000 $ 4,600,000,000            
Total consideration   $ 5,000,000,000.0            
Loss on extinguishment of debt       $ 413,000,000        
Early redemption premium $ 16,000,000